An insertion/deletion polymorphism in intron 18 of the type B human natriuretic peptide receptor gene is not associated with cerebral infarction

Hypertension Research

Volumn 23, Issue 2, 2000, Pages 173-176

  Rahmutula, Dolkun ^a   Nakayama, Tomohiro ^a   Soma, Masayoshi ^a   Takahashi, Yukie ^a   Uwabo, Jiro ^a   Sato, Mikano ^a   Izumi, Yoichi ^a   Kanmatsuse, Katsuo ^a   Ozawa, Yukio ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Association; Cerebral infarction; Natriuretic peptide receptor; Polymorphism

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

ADULT; AGED; BRAIN INFARCTION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE;

EID: 0034037394     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.23.173     Document Type: Conference Paper

References (22)

1. Rigat B, Hubert C, Alhenc-Gelas F, et al. An insertion/ deletion in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
2. Cambien F, Poirier O, Lecerf L, et al: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
3. Zhao Y, Higashimori K, Higaki J, et al: Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res 1994; 17: 55-57.
4. Samuni NJ, Thompson JR, O'Toole L, et al: A metaanalysis of the association of the deletion allele of the angiotensin converting enzyme gene with myocardial infarction. Circulation 1996; 94: 708-712.
5. Tiret L, Ricard S, Poirier O, et al: Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM study. J Hypertens 1995; 13: 311-317.
6. Kamitani A, Rakugi H, Higaki J, et al: Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995; 25: 950-953.
7. Kowtows T, Koike G, Yee TW, et al: Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345: 1600-1603.
8. Eichner JE, Kuller LH, Orchard TJ, et al: Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 1993; 71: 160-165.
9. Luc G, Bard JM, Arveiler D, et al: Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: the ECTIM Study. Arterioscler Thromb 1994; 14: 1617-1624.
10. Tiret L, Knijff DP, Menzel HJ, et al: ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations: The EARS Study. European Artherosclerosis Research Study. Arterioscler Thromb 1994; 14: 1617-1624.
11. Nakata Y, Kowtows T, Rakugi H, et al: Polymorphism of the apolipoprotein E and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischemic. Hypertension 1996; 27: 1205-1209.
12. Nakata Y, Kowtows T, Rakugi H, et al: Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am J Hypertens 1997; 10: 1391-1395.
13. Kario K, Kanai N, Saito K, et al: Ischemic Stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 1996; 93: 1630-1633.
14. Igaki T, Itoh H, Suga SI, et al: Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide. Hypertens Res 1998; 21: 7-13.
15. Suga S, Nakao K, Itoh H, et al: Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta: possible existence of a vascular natriuretic peptide system. J Clin Invest 1992; 90: 1145-1149.
16. Komatsu Y, Itoh H, Suga S, et al: Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells: role of the vascular natriuretic peptide system in vascular growth inhibition. Circ Res 1996; 78: 606-614.
17. Wei C-M, Kim CH, Khraibi AA, et al: Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and vasorelaxing action in vivo. Hypertension 1994; 23 (part 2): 903-907.
18. Rehemdula D, Nakayama T, Soma M, et al: Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension. Circ Res 1999; 84: 605-610.
19. Rubattus S, Volpe M, Kreutz R, et al. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nature Gent 1996; 13: 429-434.
20. Sharma P: Genes for ischaemic stroke: strategies for their detection. J Hypertens 1996; 14: 277-285.
21. Margaglione M, Celentano E, Grenadine E, et al: Deletion polymorphism in the angiotensin-converting enzyme gene in patient with a history of ischemic stroke. Arterioscler Thromb Vasc Biol 1996; 16: 304-309.
22. Catto A, Carter AM, Barrett JH, et al: Angiotensin converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke 1996; 27: 435-440.